These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 6223752)
1. The active rosette mixed-lymphocyte reaction: an early marker of lymphocyte activation linked to HLA-D-DR differences. Wybran J; Dupont E Clin Immunol Immunopathol; 1983 Apr; 27(1):51-5. PubMed ID: 6223752 [TBL] [Abstract][Full Text] [Related]
2. HLA-DR typing as a predictor of MLC compatibility. Radvany RM; Vaisrub N Transplantation; 1984 Oct; 38(4):347-51. PubMed ID: 6238455 [TBL] [Abstract][Full Text] [Related]
3. Identification of unrelated HLA-identical bone marrow donors: RFLP, oligotyping and PCR fingerprinting for HLA class II compared to MLC responses. Mazzola G; el-Borai MH; Berrino M; Cornaglia M; Amoroso A Bone Marrow Transplant; 1993; 11 Suppl 1():24-7. PubMed ID: 8095414 [TBL] [Abstract][Full Text] [Related]
4. Activation of cytotoxic T lymphocytes in HLA-A, -B and -C-identical responder-stimulator pairs. I. Variations in generation of anti-class-II CTL in primary mixed lymphocyte cultures. Breuning MH; Breur BS; Engelsma MY; Iványi P Tissue Antigens; 1984 Aug; 24(2):81-9. PubMed ID: 6238446 [TBL] [Abstract][Full Text] [Related]
5. HLA-DR human histocompatibility leukocyte antigens-restricted lymphocyte-monocyte interactions in the release from monocytes of acidic isoferritins that suppress hematopoietic progenitor cells. Broxmeyer HE; Juliano L; Lu L; Platzer E; Dupont B J Clin Invest; 1984 Apr; 73(4):939-53. PubMed ID: 6231314 [TBL] [Abstract][Full Text] [Related]
6. HLA-D and -DR antigens on human amniotic fluid cells. I. Lack of expression of HLA-D. Valentine-Thon E; Kreeb G; Grosse-Wilde H; Passarge E Tissue Antigens; 1983 Feb; 21(2):138-47. PubMed ID: 6221440 [TBL] [Abstract][Full Text] [Related]
7. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules. Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479 [TBL] [Abstract][Full Text] [Related]
8. [Genetic control of mixed lymphocyte culture]. Hajek-Rosenmayr A Wien Klin Wochenschr; 1980 Dec; 92(23):834-40. PubMed ID: 6242847 [TBL] [Abstract][Full Text] [Related]
9. The active T rosette: an early marker for T-cell activation. Wybran J; Dupont E Ann Immunol (Paris); 1982; 133D(2):211-8. PubMed ID: 6219610 [TBL] [Abstract][Full Text] [Related]
10. Variable MLC stimulatory capacity of neoplastic B and non-B/non-T lymphocytes expressing HLA-DR antigens. Bom-van Noorloos AA; Schreuder I; de Groot-Swings G; Ubels-Postma J; von dem Borne AE; Melief CJ Tissue Antigens; 1982 Nov; 20(5):352-63. PubMed ID: 6218653 [TBL] [Abstract][Full Text] [Related]
11. The use of phytohemagglutinin-stimulated mononuclear cell subpopulations for HLA typing studies involving chronic myelogenous leukemia patients. Callaway C; Maurer DH; Brown D; Fang W; Fehir KM; Pollack MS Transplantation; 1986 Sep; 42(3):315-7. PubMed ID: 2944260 [No Abstract] [Full Text] [Related]
12. Influence of race on the predictability of mixed lymphocyte culture identity by HLA-DR matching. Suciu-Foca N; Reed E; Rohowsky C; Lewison A; King DW Transplantation; 1983 Jan; 35(1):35-9. PubMed ID: 6218664 [TBL] [Abstract][Full Text] [Related]
13. [Mixed lymphocyte culture as a compatibility test for bone marrow transplantation]. Hajek-Rosenmayr A Wien Klin Wochenschr; 1986 Jan; 98(2):44-9. PubMed ID: 2938340 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of HLA-class II identity between unrelated individuals by serological typing, DNA-RFLP method, and mixed lymphocyte reaction. al-Daccak R; Loiseau P; Miramont P; Rabian C; Raffoux C; Colombani J Hum Immunol; 1990 Nov; 29(3):189-201. PubMed ID: 1980919 [TBL] [Abstract][Full Text] [Related]
16. Plaque-forming cells in man. III. Generation of plaque-forming cells in allogeneic in vitro cultures of HLA-D/DR-incompatible B and T lymphocytes. Tauris P; Johnsen HE; Christiansen SE; Kissmeyer-Nielsen F Scand J Immunol; 1984 May; 19(5):419-24. PubMed ID: 6233695 [TBL] [Abstract][Full Text] [Related]
17. [Increase of circulating HLA DR+ T lymphocytes in psoriasis]. Paciel J; Vignale RA; Bruno J; Vázquez G; De Anda G Med Cutan Ibero Lat Am; 1984; 12(6):497-500. PubMed ID: 6397671 [TBL] [Abstract][Full Text] [Related]
18. Lack of shared lymphocyte-stimulating determinants between H-2I and HLA-D/DR using mouse primed lymphocyte typing cells. Shaut DM; Ireland J; Scornik JC; Peck AB Hum Immunol; 1983 Jun; 7(2):105-15. PubMed ID: 6190790 [TBL] [Abstract][Full Text] [Related]
20. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules. Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]